providing first-trimester, medical and surgical safe abortion services in KwaZulu-Natal Province, South Africa” en PLoS One, Vol. 12, núm. 4, p. e0174615.
Løkeland M, Bjørge T, Iversen O-E, Akerkar R, Bjørge L, 2017, “Implementing medical abortion with mifepristone and misoprostol in Norway 1998–2013” en Int J Epidemiol, Vol. 46, núm. 2, pp. 643–651.
Nivedita K, Shanthini F, 2015, “Is It Safe to Provide Abortion Pills over the Counter? A Study on Outcome Following Self-Medication with Abortion Pills” en J Clin Diagn Res, Vol. 9, núm. 1, pp. QC01–QC04.
Norman WV, Soon JA, Maughn N, 2013, “Barriers to Rural Induced Abortion Services in Canada: Findings of the British Columbia Abortion Providers Survey (BCAPS)” en PLoS One, Vol. 8, núm. 6, p. e67023.
Popinchalk A, Sedgh G, 2019, “Trends in the method and gestational age of abortion in high- income countries” en BMJ Sex Reprod Health, Vol. 45, núm. 2, pp. 95–103.
Powell-Jackson T, Acharya R, Filippi V, Ronsmans C, 2015, “Delivering Medical Abortion at Scale: A Study of the Retail Market for Medical Abortion in Madhya Pradesh, India” en PLoS One, Vol. 10, núm. 3, p. e0120637.
Raymond E, Chong E, Winikoff, Platais B, Mary M y otros., 2019, “TelAbortion: evaluation of a direct to patient telemedicine abortion service in the United States” en Contraception, Vol. 100, pp. 173–177.
Rocca CH, Puri, M, Shrestha P, Blum, M, Maharjan D, Grossman D, Regmi K, Darney PD, Harper CC, Vermund SH, 2018, “Effectiveness and safety of early medication abortion provided in pharmacies by auxiliary nurse-midwives: A non-inferiority study in Nepal” en PLoS One, Vol. 13, núm. 1, p. e0191174.
Rogers C, Sapkota S, PauderR, Dantas JAR, 2019, “Medical abortion in Nepal: a qualitative study on women’s experiences at safe abortion services and pharmacies” en Reprod Health, Vol. 16, p. 105.
Saleem HT (Monitoring Editor), Narasimhan M, Ganatra B, Kennedy CE, and Cochrane Fertility Regulation Group, 2018, “Medical and surgical abortion for women living with HIV” en Cochrane Database Syst Rev, núm 12, p. CD012834.
Schiavon R, Troncoso E, 2020, “Inequalities in access to and quality of abortion services in Mexico: Can task-sharing be an opportunity to increase legal and safe abortion care?” en Int J Gynaecol Obstet, Vol. 150, Suppl 1, pp. 25-33.
Sedgh G, Filippi V, Owolabi OO, Singh SD, y otros, 2016, “Insights from an expert group meeting on the definition and measurement of unsafe abortion” en Int J Gynaecol Obstet, Vol. 134, núm. 1, pp. 104–106.
Sneeringera RK, Billings DJ, Ganatra B, Bairda T, 2012, “Roles of pharmacists in expanding access to safe and effective medical abortion in developing countries: A review of the literature” en Journal of Public Health Policy, Vol. 33, pp. 218–229.
Sjöström S, Kopp Kallner H, Simeonova E, Madestam A, Gemzell-Danielsson K, 2016, “Medical Abortion Provided by Nurse-Midwives or Physicians in a High Resource Setting: A Cost-EffectivenessAnalysis” en PLoS ONE, Vol. 11, núm. 6, p. e0158645.
Sudhinaraset M, Landrian A, Montagu D, Mugwanga Z, Gemmill A, 2019, “Is there a difference in women’s experiences of care with medication vs. manual vacuum aspiration abortions? Determinants of person-centered care for abortion services” en PLoS One, Vol. 14, núm. 11, p. e0225333.
Stillman M, Owolabi O, Fatusi AO, Akinyemi AI, Berry AL, Erinfolami TP, Olagunju OS, Väisänen H, Bankole A, 2020, “Women’s self-reported experiences using misoprostol obtained from drug sellers: a prospective cohort study in Lagos State, Nigeria” en BMJ Open, Vol. 10, núm. 5, p. e034670.
Suh S, 2014, “Rewriting abortion: deploying medical records in jurisdictional negotiation over a forbidden practice in Senegal” en Soc Sci Med, Vol. 108, pp. 20–33.
Vázquez-Quesada L, Shukla A, Vieitez I , Acharya R, RamaRao S, 2020, “Abortion Self-Care: A Forward-Looking Solution To Inequitable Access” en Int Perspect Sex Reprod Health, Vol. 46, Suppl 1, pp. 91-95.
Viggiano M, Faúndes A, Borges AL, y otros, 1996, “Disponibilidade de misoprostol e complicacoes de aborto provocado em Goiaˆnia” en J Bras Ginecol, Vol. 106, pp. 55–61.
Walt RP, 1992, “Misoprostol for the treatment of peptic ulcer and anti-inflammatory drug induced gastroduodenal ulceration” en N Engl J Med, Vol. 327, pp. 1575–80.
WHO, 2012, Safe abortion: technical and policy guidance for health systems, Ginebra.
Zamanian M, Reza Baneshi M, Haghdoost A , Zolala F, 2016, “Estimating the visibility rate of abortion: a case study of Kerman, Iran” en BMJ Open, Vol. 6, núm. 10, p e012761.
Конец ознакомительного фрагмента.
Текст предоставлен ООО «ЛитРес».
Прочитайте эту книгу целиком, купив полную легальную версию на ЛитРес.
Безопасно оплатить книгу можно банковской картой Visa, MasterCard, Maestro, со счета мобильного телефона, с платежного терминала, в салоне МТС или Связной, через PayPal, WebMoney, Яндекс.Деньги, QIWI Кошелек, бонусными картами или другим удобным Вам способом.
